Comparative advantage and competitiveness of COVID-19-related medical products exporters
The coronavirus disease (COVID-19) pandemic generated an upsurge in demand for medical products. Trade policy changes, including export restrictions and import reforms, have led to a shortage of medical products. The World Health Organization has recommended countries to encourage local production a...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Published: |
Tomas Bata University, Zlin
2022
|
| Online Access: | http://psasir.upm.edu.my/id/eprint/100731/ |
| _version_ | 1848863399780286464 |
|---|---|
| author | Idris, Zera Zuryana Ismail, Normaz Wana Ibrahim, Saifuzzaman |
| author_facet | Idris, Zera Zuryana Ismail, Normaz Wana Ibrahim, Saifuzzaman |
| author_sort | Idris, Zera Zuryana |
| building | UPM Institutional Repository |
| collection | Online Access |
| description | The coronavirus disease (COVID-19) pandemic generated an upsurge in demand for medical products. Trade policy changes, including export restrictions and import reforms, have led to a shortage of medical products. The World Health Organization has recommended countries to encourage local production and identify various import sources for medical products to ensure sustainable healthcare capacity to combat the COVID-19 pandemic and any similar events in the future. This study aims to examine the comparative advantages and competitiveness in producing medical products among top exporters. The contribution of this study is the ability to identify various import sources specific to developing countries. From the exporter’s perspective, this study allows countries to recognize their existing competitive strengths in the medical products trade, allowing them to strategize and compete in the international markets of medical products. Using Balassa’s revealed comparative advantage index, this study analyzes 25 primary medical product exporters, identifying several countries with a comparative advantage in producing medical products. Medicines are primarily dominated by high-income countries, including Switzerland and Germany, whereas middle-income countries, such as China and Malaysia, are more specialized in medical supplies, medical equipment, and personal protective products. This finding provides a basis for policy formulation that can facilitate the process of building a sustainable healthcare capacity. |
| first_indexed | 2025-11-15T13:32:18Z |
| format | Article |
| id | upm-100731 |
| institution | Universiti Putra Malaysia |
| institution_category | Local University |
| last_indexed | 2025-11-15T13:32:18Z |
| publishDate | 2022 |
| publisher | Tomas Bata University, Zlin |
| recordtype | eprints |
| repository_type | Digital Repository |
| spelling | upm-1007312023-09-11T07:16:18Z http://psasir.upm.edu.my/id/eprint/100731/ Comparative advantage and competitiveness of COVID-19-related medical products exporters Idris, Zera Zuryana Ismail, Normaz Wana Ibrahim, Saifuzzaman The coronavirus disease (COVID-19) pandemic generated an upsurge in demand for medical products. Trade policy changes, including export restrictions and import reforms, have led to a shortage of medical products. The World Health Organization has recommended countries to encourage local production and identify various import sources for medical products to ensure sustainable healthcare capacity to combat the COVID-19 pandemic and any similar events in the future. This study aims to examine the comparative advantages and competitiveness in producing medical products among top exporters. The contribution of this study is the ability to identify various import sources specific to developing countries. From the exporter’s perspective, this study allows countries to recognize their existing competitive strengths in the medical products trade, allowing them to strategize and compete in the international markets of medical products. Using Balassa’s revealed comparative advantage index, this study analyzes 25 primary medical product exporters, identifying several countries with a comparative advantage in producing medical products. Medicines are primarily dominated by high-income countries, including Switzerland and Germany, whereas middle-income countries, such as China and Malaysia, are more specialized in medical supplies, medical equipment, and personal protective products. This finding provides a basis for policy formulation that can facilitate the process of building a sustainable healthcare capacity. Tomas Bata University, Zlin 2022-03 Article PeerReviewed Idris, Zera Zuryana and Ismail, Normaz Wana and Ibrahim, Saifuzzaman (2022) Comparative advantage and competitiveness of COVID-19-related medical products exporters. Journal of Competitiveness, 14 (1). 61 - 79. ISSN 1804-171X; ESSN: 1804-1728 https://www.cjournal.cz/index.php?hid=clanek&bid=archiv&cid=435&cp= 10.7441/joc.2022.01.04 |
| spellingShingle | Idris, Zera Zuryana Ismail, Normaz Wana Ibrahim, Saifuzzaman Comparative advantage and competitiveness of COVID-19-related medical products exporters |
| title | Comparative advantage and competitiveness of COVID-19-related medical products exporters |
| title_full | Comparative advantage and competitiveness of COVID-19-related medical products exporters |
| title_fullStr | Comparative advantage and competitiveness of COVID-19-related medical products exporters |
| title_full_unstemmed | Comparative advantage and competitiveness of COVID-19-related medical products exporters |
| title_short | Comparative advantage and competitiveness of COVID-19-related medical products exporters |
| title_sort | comparative advantage and competitiveness of covid-19-related medical products exporters |
| url | http://psasir.upm.edu.my/id/eprint/100731/ http://psasir.upm.edu.my/id/eprint/100731/ http://psasir.upm.edu.my/id/eprint/100731/ |